Pet DRx, Inc. (NASDAQ:VETS) today announced that the Company was added to the Russell Microcap Index on June 27, 2008, when Russell Investments reconstituted its family of U.S. indexes.
“We are very pleased that Pet DRx has been included in the Russell Microcap Index,” commented Bob Wallace, the Company’s chief executive officer. “Our addition to this widely recognized index will provide Pet DRx with a higher profile in the investment community and increased exposure to institutional investors.”
Membership in the Russell Microcap Index remains in place for one year. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $4.4 trillion in assets are currently benchmarked to Russell indexes. Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000 Index, the Russell 2000 Index and Russell Microcap Index. The Microcap Index includes the smallest 1,000 members of the Russell 2000, and the next 1,000 smallest stocks by market capitalization.
About Pet DRx
Pet DRx Corporation, headquartered in Brentwood, Tennessee, provides veterinary primary care and specialized services to companion animals through a network of fully-owned veterinary hospitals. The Company currently owns and operates 26 leading veterinary hospitals in the state of California, which it has organized into unique, regional “hub and spoke” networks. Pet DRx provides a full range of general medical treatments for companion animals, including (i) preventive care, such as examinations, vaccinations, spaying/neutering and dental care and (ii) a broad range of specialized diagnostic and medical services, such as internal medicine, surgery, cardiology, ophthalmology, dermatology, oncology, neurology, x-ray, ultrasound and other services.
SAFE HARBOR STATEMENT
Certain statements and information included in this press release, including statements as to the potential benefits of being included in the Russell Microcap Index, and to the expected operations of the Company, its prospects for growth, and future product and service offerings constitute “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including, but not limited to, the ability of the Company to successfully acquire, integrate and operate veterinary hospitals and clinics, requirements or changes affecting the businesses in which the Company is engaged, veterinary services trends, including factors affecting supply and demand, dependence on acquisitions for growth, labor and personnel relations, changing interpretations of generally accepted accounting principles and other risks detailed from time to time in the Company’s SEC reports, including its Current Report on Form 8-K, as amended, filed on April 4, 2008, its Registration Statement on Form S-4, as amended, filed on November 8, 2007, and its quarterly report on Form 10Q for the period ending March 31, 2008. These forward-looking statements speak only as of the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contacts:
Gregory J. Eisenhauer, CFA, EVP & Chief
Financial Officer
geisenhauer@petdrx.com
408-236-7428
www.petdrx.com
or
Investor
Contacts:
Lippert/Heilshorn & Associates, Inc.
Bruce
Voss
bvoss@lhai.com
Don
Markley
dmarkley@lhai.com
310-691-7100
www.lhai.com
